Core Scientific Inc. (CORZ) 12-Month Stock Forecast & Price Target Cone

$13.25 -8.18% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $13.03

Core Scientific Inc. (CORZ) carries a Roarable Rating of E (Strong Sell) with 25/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE E • RED ALERT Cap $4.26B
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on CORZ Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is CORZ stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼

As of 2026-11-03, Core Scientific Inc. (NASDAQ: CORZ) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 25/100 at a spot price of $13.25 (-8.18% 1D, market cap $4.26B). Pillar breakdown: Fundamental Cash Engine 4/20, Institutional 13F & Options Flow 5/20, Executive Insider Alignment 8/20, FRED Macro Regime Fit 3/20, and SEC Balance-Sheet Forensics 5/20. Across 1096 tracked Financials issuers, CORZ ranks #1057 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does CORZ compare to ENVA and NNI in the Financials sector?
▼

Within the Financials sector (Finance: Consumer Services), CORZ carries a Roarable E (25/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of -35.0%. By comparison, ENVA (Enova International Inc.) holds a C- grade (61/100 RQD, P/E 14.4x, ROIC 17.1%, cap $4.26B) and NNI (Nelnet Inc.) posts a D+ grade (53/100 RQD, P/E 10.3x, ROIC 11.6%, cap $4.38B). Among the 5-stock peer group, NNI leads on earnings multiple (10.3x) while DAVE leads on capital efficiency (55.3% ROIC).

✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for CORZ?
▼

Per CORZ's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001839341), Core Scientific Inc. generated $319.0M in revenue (-37.5% YoY), -$288.6M in net income, and -$450.8M in free cash flow against $2.35B in total assets and $1.06B in total debt. Key quantitative strengths: Established market leader in Financials with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
EXT / AFTER-HRS: $13.03 (-1.66%)🧬 Dilution Drag (+1.92% YoY Shares)⚙️ Cash Engine: 4/20 (E) • 0% FCF Margin
Verify 90D Bucket Audit →
📊 Historical Track Record Warning: Scores below 50 (25/100 · E) historically underperformed SPY in 71% of rolling 90-day windows (-10.7% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →
RQD QUANT TACHOMETERRED ALERT • E
025507510025
3-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw E · Rk E
Cash (4)Whales (5)SEC (8)Macro (3)CEO (5)
Each axis scored 0–20
12M PRICE TARGET CONE-14.9% Base Target
$32 Bull$11 Base$9 Bear
📬 FREE CORZ RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for CORZ)Realized 20D OHLCV Swing Band: ±12.5%
Deterministic 5-Pillar Attribution (25/100 Composite)
🔍 WHY CORZ SCORES 25/100 (E) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: SEC 10-K Forensic Risk+8/20 pts (32% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 5/9

▲ #2 Bullish Driver: Whale & Options Positioning+5/20 pts (20% of score)

20D Institutional Volume Accumulation (±12.5% realized swing band)

▼ #1 Drag / Risk Factor: Macro Regime Fit4/20 pts (-16 pt drag)

Macro rate sensitivity & RSI-14 (40.8) create a -16 pt regime headwind

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)
33
Grade E$13.51+5.5% Next Q
Q2 (-2Q)
30
Grade E$14.25+5.3% Next Q
Q3 (-1Q)
28
Grade E$15.00-11.7% Next Q
Current
25
Grade E$13.25-10.7% Hist 90D α
Trajectory: E (33) → E (25)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a CORZ Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While CORZ currently carries a cautious 25/100 (E) rating due to Macro Regime Fit (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Financials with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($15.97) and Max Pain ($13.91) forces dealer call-delta covering toward $31.98.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Dilution Drag (+1.92% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $CORZ• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “CORZ Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
INTERACTIVE 12-MONTH POSITION SIMULATOR

Drag to Test Your CORZ Position Size: $10,000

Shares at $13.25: 754.7 sh
$1,000$10,000$25,000$50,000$100,000
12M Bear Case FloorTarget $8.80
$6,642
$-3,358 (-33.6%)
12M Consensus BaseTarget $11.28
$8,513
$-1,487 (-14.9%)
12M Bull Case BreakoutTarget $31.98
$24,136
+$14,136 (+141.4%)

Wall Street Analyst Breakdown & Historical Accuracy Audit (35 Desks)

Street Historical Accuracy: 64/100
● Strong Buy / Buy: 17● Hold: 9● Sell: 9
Wall Street FirmStance12M Target1Y AccuracyTrack Grade
Morgan StanleyInstitutional Equity DeskHOLD$1274%A
Goldman SachsSector Coverage LeadUNDERPERFORM$3069%B
JP MorganUS Large-Cap ResearchSELL$1058%C
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring CORZ)

  • ✓Walkthrough of CORZ's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
CORZ // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -37.20%▼ DESCENDING CHANNEL
2026-11-03O $14.43H $14.43L $13.25C $13.25VOL 18.92M
RES: $15.41SUP: $10.82SMA50: $15.97SMA200: $19.59
$31.73$26.47$21.20$15.94$10.68RES $15.41SUP $10.82$13.252026-05-042026-06-182026-08-052026-09-212026-11-03
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

CORZ Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)
22.3%/yr Implied 5Y Growth

vs. -37.5% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on CORZ today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for CORZ. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for CORZ today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (CORZ)

Financials Rank #1057 of 1096 ⚔️ ENVA vs CORZ Full Matrix →

1. Head-to-Head Financials Peer Comparison (CORZ vs. ENVA, NNI, DAVE, SEZL)

Industry: Finance: Consumer Services (156 Tracked Issuers)

Across 1096 tracked Financials securities in the Roarable RQD universe, Core Scientific Inc. (CORZ) ranks #1057 by composite RQD confidence (25/100, grade E) and #302 by equity capitalization ($4.26B). Within this direct 5-issuer industry benchmark cohort, NNI leads on earnings valuation at 10.3x trailing P/E, while DAVE leads on capital efficiency and profitability with 55.3% ROIC and — gross margin. SEZL currently holds the highest overall quantitative score in the immediate peer group at 79/100 (B+) compared with CORZ at 25/100 (E).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
CORZ ACTIVE
Core Scientific Inc.
E 25/100 — — -35.0% -8.18% $4.26B Benchmark Subject
ENVA
Enova International Inc.
C- 61/100 14.4x — 17.1% -3.84% $4.26B /enva-vs-corz →
NNI
Nelnet Inc.
D+ 53/100 10.3x — 11.6% -0.87% $4.38B /nni-vs-corz →
DAVE
Dave Inc.
B+ 76/100 21.8x — 55.3% -5.38% $4.04B /dave-vs-corz →
SEZL
Sezzle Inc.
B+ 79/100 — — 38.6% +0.74% $4.56B /sezl-vs-corz →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001839341

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Core Scientific Inc. (CORZ) reported GAAP revenue of $319.0M (-37.5% vs. FY2024 revenue of $510.7M , and -36.5% cumulative change since FY2023) , GAAP net income of -$288.6M, operating cash flow of $278.3M, and free cash flow of -$450.8M (-765.7% YoY). On the balance sheet, CORZ closed FY2025 with $2.35B in total assets against $1.06B in total debt (Altman Z-Score: N/A, Piotroski F-Score: 5/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-12-31 $319.0M -$288.6M $278.3M -$450.8M $2.35B $1.06B
FY2024 (FY) 2024-12-31 $510.7M -$1.44B $42.9M -$52.1M $1.48B $1.09B
FY2023 (FY) 2023-12-31 $502.4M -$246.5M $65.1M $42.5M $2.55B $596.8M

3. CORZ Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is CORZ stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-03, Core Scientific Inc. (NASDAQ: CORZ) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 25/100 at a spot price of $13.25 (-8.18% 1D, market cap $4.26B). Pillar breakdown: Fundamental Cash Engine 4/20, Institutional 13F & Options Flow 5/20, Executive Insider Alignment 8/20, FRED Macro Regime Fit 3/20, and SEC Balance-Sheet Forensics 5/20. Across 1096 tracked Financials issuers, CORZ ranks #1057 in composite RQD confidence.

How does CORZ compare to ENVA and NNI in the Financials sector?

Within the Financials sector (Finance: Consumer Services), CORZ carries a Roarable E (25/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of -35.0%. By comparison, ENVA (Enova International Inc.) holds a C- grade (61/100 RQD, P/E 14.4x, ROIC 17.1%, cap $4.26B) and NNI (Nelnet Inc.) posts a D+ grade (53/100 RQD, P/E 10.3x, ROIC 11.6%, cap $4.38B). Among the 5-stock peer group, NNI leads on earnings multiple (10.3x) while DAVE leads on capital efficiency (55.3% ROIC).

What are the biggest fundamental strengths and SEC risk factors for CORZ?

Per CORZ's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001839341), Core Scientific Inc. generated $319.0M in revenue (-37.5% YoY), -$288.6M in net income, and -$450.8M in free cash flow against $2.35B in total assets and $1.06B in total debt. Key quantitative strengths: Established market leader in Financials with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is CORZ trading relative to its 50-day, 200-day, and 52-week technical levels?

CORZ last traded at $13.25 (-8.18% on volume of 18,916,784 shares), positioning the stock -17.03% below its 50-day simple moving average ($15.97) and -32.36% below its 200-day simple moving average ($19.59). Across its 52-week range of $12.31 to $30.46, CORZ sits at the 5.2% percentile with a 14-day RSI of 40.8 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($11.59 to $14.91).

ROARABLE RATING BRIEF • RQD 25/100 (E) ✓ STAGE-C NUMBER FIREWALL VERIFIED

CORZ — Core Scientific Inc.: What the Facts Mean to a Prospective Investor

Engine: anthropic/claude-haiku-5.5
As of: 2026-11-02T15:21:18Z

Roarable Rating Brief: What This Means to a Prospective Investor

Per the Roarable RQD rating, CORZ scores 26 out of 100 and carries a letter grade of E, labeled "Roarable Strong Sell — Forensic Risk / Avoid." The Fundamental Cash Engine pillar scores 4 of 20, reflecting ROIC of -35% and an FCF yield of -9.72%. The Whale 13F Flow pillar scores 6 of 20, based on institutional accumulation and options positioning. The Insider Conviction pillar scores 5 of 20, based on SEC Form 4 and Congressional PTR cluster flow. The Macro Regime Fit pillar scores 3 of 20, reflecting a Beta of 1.12 and sector sensitivity. The Forensic Balance Sheet pillar scores 8 of 20, reflecting an Altman Z of 2.5, a Piotroski F of 5/9, and Debt/Equity of 0.5.

For a prospective investor, the weakest pillars sit on the cash-generation and macro-fit side, while the balance sheet is the strongest of the five but still scores below mid-range. Upside drivers would need to come from a reversal in operating cash flow, which the source data shows as negative. Valuation tradeoffs are visible in the forward P/E of 29 set against negative trailing EPS of -0.9. The rating frames this as a forensic-risk profile rather than a cash-generative one.

Business

Core Scientific Inc. is a NASDAQ-listed issuer classified under the Financials sector and the Finance: Consumer Services industry. Per the SEC financials, the company reported FY 2025 revenue of $319.0M. The Butterfly Supply-Chain Graph lists supply chain as "NONE," so no upstream or downstream relationships are mapped.

Recent Catalysts & News Wire Analysis

Per the recent news wire, the headlines are dated within the prior 15 hours of the data timestamp. Flagged items include a Seeking Alpha report headlined "Core Scientific Wins AMD's Approval, As Meltdown/Bottoming Offers Cheap Buying Opportunity," presented as a yellow-light market wire item. A 24/7 Wall St. report flagged as a red-light risk watch item notes that Applied Digital fell 4% ahead of earnings and that IREN and Core Scientific also dropped 4%. A GuruFocus report headlined "Core Scientific (CORZ) Stock Dips Amid Elevated Options Volatili" is also present as a yellow-light wire. The remaining wire items are general market-action summaries from Yahoo Finance UK, Simply Wall St, and TradingView. The Butterfly Supply-Chain Graph reports no proprietary signals and no butterfly links.

Butterfly Effect: 2nd-Order Supply-Chain & Sector Ripples

— The Butterfly Supply-Chain Graph lists supply chain as "NONE," with empty butterfly links and empty proprietary signals.

Analyst View & Smart Money Ownership

— The analyst data section is "NONE," and the holders section is "NONE," so no consensus rating, price targets, SEC Form 4 insider trades, 13F whale holdings, or Congressional trades are provided.

Open Questions

  • What is the company's revenue mix and customer base, given that the source data provides only a sector and industry classification?
  • What drove the reduction in cash from $836.2M in FY 2024 to $311.4M in FY 2025 alongside FCF of $-450.8M?
  • What is the trailing P/E and EV/EBITDA, which the source data marks as unavailable?
  • What institutional and insider ownership exists, given that both holders and analyst data are empty?
  • What is the basis for the AMD approval referenced in the Seeking Alpha headline, and how does it relate to reported financials?

CORZ Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Core Scientific Inc. (CORZ) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to CORZ Debate Forum (3) ↓
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

CORZ Bull vs. Bear Conversation Board — What's Your Call at $13.25?

🐂 33% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON CORZ 🐻 67% BEARISH CONVICTION
1. Pick Your Side on CORZ:
💡 Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
RO RoarDesk_Moderator Roarable Research Desk 🐻 BEARISH 🎯 Target: $12.70 (-12.0%)
📌 Pinned Debate

🔥 Official Bull vs. Bear Debate: Is CORZ (E • RQD 26/100) a Buy at $14.43?

Welcome to the CORZ (Core Scientific Inc.) Roar Pit. Current RQD Composite is 26/100 (Roarable Strong Sell — Forensic Risk / Avoid) in Finance: Consumer Services. Bulls point to operating leverage and sector positioning, while bears focus on macro rate sensitivity and margin execution. Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.

SH ShortSeller_Dan Forensic Accounting Watch 🐻 BEARISH 🎯 Target: $11.26 (-22.0%)
Spot @ $14.43

Pump the brakes on CORZ — check the valuation vs. margin headwinds

Everyone in here is repeating the bull case on CORZ, but look at what you are paying: current EV/EBITDA multiples with tightening sector spreads. Unless Core Scientific Inc. expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.

MA MacroHawk_NYC Verified K Arena Trader 🐂 BULLISH 🎯 Target: $18.04 (+25.0%)
Spot @ $14.43

CORZ cash flow & RQD setup is being underpriced by the Street here

Looking at the 5-pillar RQD breakdown on CORZ, the market is fixating on short-term headline noise in Finance: Consumer Services and ignoring the balance sheet and cash flow trajectory. At $14.43 (52-wk range $12.31 - $30.46), any beat on forward guidance forces shorts and underweight funds to chase.

LIVE TAPE SPY $752.10 -1.80% QQQ $681.09 -3.60% DIA $519.34 -1.08% IWM $279.14 -1.68% NVDA $204.64 -4.22% AAPL $344.63 -1.23% MSFT $521.91 -1.55% TSLA $399.81 -0.86% PLTR $184.11 -6.27% SOFI $16.76 -4.83% IBIT $43.35 -5.42% GLD $361.65 -3.59%